Generation of induced pluripotent stem cell lines from five individuals from two families carrying a pathogenic Dutch MYBPC3 founder variant with variable degrees of hypertrophic cardiomyopathy

Stem Cell Res. 2025 Aug:86:103697. doi: 10.1016/j.scr.2025.103697. Epub 2025 Mar 16.

Abstract

Hypertrophic cardiomyopathy (HCM) is often caused by pathogenic or likely pathogenic variants, of which 30-50 % involve a variant in the gene encoding cardiac myosin-binding protein-C (MYBPC3). We generated human induced pluripotent stem cell lines from five individuals from two families carrying a pathogenic Dutch MYBPC3 founder variant: c.2373insG (n = 2) and c.2827C > T (n = 3), with highly variable disease expression. Peripheral blood mononuclear cells were reprogrammed using episomal plasmids. All cell lines express pluripotent markers, exhibit a normal karyotype, and could differentiate into derivatives of each germ layers in vitro. These cell lines can serve as disease model to investigate HCM pathogenesis.

MeSH terms

  • Adult
  • Cardiomyopathy, Hypertrophic* / genetics
  • Cardiomyopathy, Hypertrophic* / metabolism
  • Cardiomyopathy, Hypertrophic* / pathology
  • Carrier Proteins* / genetics
  • Carrier Proteins* / metabolism
  • Cell Differentiation
  • Cell Line
  • Female
  • Humans
  • Induced Pluripotent Stem Cells* / cytology
  • Induced Pluripotent Stem Cells* / metabolism
  • Induced Pluripotent Stem Cells* / pathology
  • Male
  • Middle Aged
  • Netherlands
  • Pedigree

Substances

  • myosin-binding protein C
  • Carrier Proteins